Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 3 , Pages 237-241 , June 2006

Menstrual Control in the Developmentally Delayed Adolescent: New Treatment Options

  • Lawrence S. Amesse, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Lawrence S. Amesse, MD, PhD, Wright State University Boonshoft School of Medicine, Department of Obstetrics and Gynecology, 128 Apple Street, Suite 3800 CHE, Dayton, OH 45409
    • ,
  • Casey Boyce, MD
    • ,
  • Teresa Pfaff-Amesse, MD

References 

  1. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol. 2001;14:3
  2. Larsson G, Milsom I, Lindstedt G, et al. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. Contraception. 1992;46:327
  3. Sucato G, Gold M. Extended cycling of oral contraceptive pills of adolescents. J Pediatr Adolesc Gynceol. 2002;15:325
  4. Schlesselman JJ. Oral contraceptives and neoplasia of the uterine corpus. Contraception. 1991;43:557
  5. Audet MC, Moreau M, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA. 2001;285:2347
  6. Harel Z, Riggs S, Vaz R, et al. Adolescents' experience with the combined estrogens and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynceol. 2005;18:85
  7. Stewart FH, Kaunitz AM, Laguardia KD, et al. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet Gynecol. 2005;105:1389
  8. London RS. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. J SOGC. 1993;15:925
  9. Basnayake S, Thapa S. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects. Adv Contracept Deliv Syst. 1986;2:307
  10. Bonny AE, Britto MT, Huang B, et al. Weight gain, adiposity, and eating behaviors among adolescent females on depo medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol. 2004;17:109
  11. Cromer BA, Blair JM, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depo medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), oral contraceptives. J Pediatr. 1996;129:671
  12. Lara-Torre E, Edwards CP, Perlman S, et al. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2004;17:17
  13. Erian J. Endometrial ablation in the treatment of menorrhagia. Br J Obstet Gynaecol. 1994;Suppl 11:19
  14. London R, Holzman M, Rubin D, et al. Payer cost savings with endometrial ablation therapy. Am J Manage Care. 1999;5:889
  15. Brooks PG, Clouse J, Morris LS. Hysterectomy vs. resectoscopic endometrial ablation for the control of abnormal uterine bleeding. A cost-comparative study. J Reprod Med. 1994;39:755
  16. Zurawin RK, Pramanik S. Endometrial balloon ablation as a therapy for intractable uterine bleeding in an adolescent. J Pediatr Adolesc Gynecol. 2001;14:119
  17. Viols GA, Aletebi FA, Eskandar MA. Endometrial thermal ablation with the ThermaChoice system: effect of intrauterine pressure and duration of treatment. J Am Assoc Gynecol Laparosc. 2000;7:325
  18. Bongers MY, Mol BW, Dijkhuizen FP. Is balloon ablation as effective as endometrial electroresection in the treatment of menorrhagia?. J Laparoendosc Adv Surg Tech. 2000;10:85
  19. Bongers MY, Bourdrez P, Mol BW, et al. Randomized controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOB. 2004;111:1095
  20. Obstetrics-Gynecology Devices Panel Meeting Summaries, Department of Health and Human Services, Food and Drug Administration, Volume I, Rockville, Maryland, October 6–7, 1997
  21. Romer T, Muller J, Foth D. Hydrothermal ablation. A new simple method for coagulating endometrium in patients with therapy-resistant recurring hypermenorrhea. Contrib Gynecol Obstet. 2000;20:154
  22. Summary of Safety and Effectiveness Data: HerOption Uterine Cryoablation Therapy System. Cryogen, Inc. Rockville, MD: US Food and Drug Administration, Center of Devices and Radiologic Health; 2001;97:S21
  23. Townsend DE, Dulbea AJ, Wilkes MM. Durability of treatment effects after endometrial cryoablation versus rollerball electroablation for abnormal uterine bleeding: two-year results of a multicenter randomized trial. Am J Obstet Gynecol. 2003;188:699
  24. Cooper J, Gimpelson R, Laberge P. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc. 2002;9:418
  25. Sharp NC, Cronin N, Feldberg I, et al. Microwaves for menorrhagia: a new fast technique for endometrial ablation. Lancet. 1995;346:1003
  26. Koh CH. A new technique and system for simplifying total laparoscopic hysterectomy. J Am Assoc Gynecol Laparosc. 1998;5:187
  27. Jenkins TR. Laparoscopic supracervical hysterectomy. Am J Obstet Gynecol. 2004;191:1875
  28. Ewen SP, Sutton CJ. Advantages of laparoscopic supra-cervical hysterectomy. Baillieres Clin Obstet Gynaecol. 1995;9:707

PII: S1083-3188(06)00077-5

doi: 10.1016/j.jpag.2006.02.012

Journal of Pediatric and Adolescent Gynecology
Volume 19, Issue 3 , Pages 237-241 , June 2006

Article Tools